Table 2 Ophthalmology data.

From: Longitudinal anatomical and visual outcome of macular telangiectasia type 2 in Asian patients

Eye

SphEq(D)

Follow-up period(yr)

LogMAR

Grade$

MNV

FTMH

Initial

Final

Change

Initial

Final

Initial

Final

Initial

Final

1R

2.13

14.0

0.10

0.22

0.12

2

3

    

1L

2.25

14.0

0.10

0.22

0.12

2

4

    

2R

3.50

9.7

− 0.08

− 0.08

0.00

3

4

    

2L

3.25

9.7

− 0.08

− 0.08

0.00

3

3

    

3R

− 1.25

7.9

− 0.08

− 0.08

0.00

0

0

    

3L

0.00

7.9

0.30

0.40

0.10

2

3

   

 +#

4R

1.00

5.2

− 0.08

− 0.08

0.00

0

0

    

4L

0.00

5.2

0.52

0.70

0.18

2

2

    

5R

− 0.50

13.3

0.52

0.52

0.22

2

2

Nonexudative

Nonexudative

  

5L

− 0.50

13.3

0.30

0.52

0.22

2

4

Nonexudative

Nonexudative

  

6R

0.50

2.2

− 0.08

0.05

0.12

3

3

    

6L

0.75

2.2

− 0.08

− 0.08

0.00

0

0

    

7R

− 1.88

5.4

0.05

0.22

0.18

0

2

    

7L

− 1.50

5.4

− 0.08

0.00

0.08

2

2

    

8R

0.25

8.0

0.00

0.15

0.15

3

4

    

8L

0.63

8.0

0.30

1.00

0.70

3

3

  

 + 

 + 

Ave

 

8.2

0.09

0.23

0.14*

      
  1. SphEq spherical equivalent. LogMAR logarithm of minimum angle of resolution. MNV macular neovascularization. FTMH full-thickness macular hole.
  2. #The eye underwent surgery for FTMH.
  3. *p = 0.008 using mixed model.
  4. $Grade was determined based on Simple Classification System11.